Related Experiment Video
Updated: Jun 4, 2026
03:57
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD
Qian Zhang1, Junsi Qiu, Haiming Li
1Division of Nephrology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China.
Journal of the American Society of Nephrology : JASN
|February 22, 2011
Summary
Cyclooxygenase 2 (COX2) drives parathyroid gland hyperplasia in chronic kidney disease (CKD) and end-stage renal disease (ESRD). Inhibiting COX2 may offer a new therapeutic strategy for secondary hyperparathyroidism.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Secondary hyperparathyroidism (SHPT) is common in chronic kidney disease (CKD), driven by parathyroid gland (PTG) hyperplasia.
- The mechanisms behind PTG hyperplasia in uremia are not fully understood.
Purpose of the Study:
- To investigate the role of cyclooxygenase 2 (COX2) in parathyroid gland hyperplasia associated with uremia.
- To explore COX2 as a potential therapeutic target for secondary hyperparathyroidism in end-stage renal disease (ESRD).
Main Methods:
- Examined COX2 expression and cell proliferation markers (PCNA) in parathyroid glands from ESRD patients and a 5/6-nephrectomy rat model.
- Assessed the effects of the COX2 inhibitor celecoxib on parathyroid gland size, PTH levels, and cell proliferation in uremic rats.
Main Results:
- Increased COX2 expression and proliferation markers (PCNA) were observed in the parathyroid glands of ESRD patients and uremic rats.
- Uremic rats showed higher serum PTH levels and larger parathyroid glands, which were significantly reduced by celecoxib treatment.
- COX2 inhibition attenuated cell proliferation and serum PTH levels in the rat model.
Conclusions:
- Aberrant COX2 expression contributes to parathyroid gland hyperplasia and secondary hyperparathyroidism in ESRD.
- Targeting the COX2 pathway presents a promising therapeutic avenue for managing hyperparathyroidism in kidney disease.
Related Concept Videos
00:59The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...